Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years

Xiaoge Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0167-2362; OpenAlex author ID A5057072589. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 5

  1. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc. Last author DOI 10.1186/s11658-024-00611-8↗
  2. UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ijo.2023.5500↗
  3. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.927640↗
  4. Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2020.01220↗
  5. Immunotherapy in pancreatic cancer: New hope or mission impossible? Co-author DOI 10.1016/j.canlet.2018.10.045↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wen Fu · 3 shared papers, 2022–2024 · strength 0.56
  2. Qiuran Xu · 2 shared papers, 2022–2024 · strength 0.37
  3. Jiahong Jiang · 2 shared papers, 2019–2020 · strength 0.22
  4. Dongsheng Huang · 2 shared papers, 2019–2020 · strength 0.22
  5. Liu Yang · 2 shared papers, 2019–2020 · strength 0.22
  6. Weiwei Jin · 1 shared paper, 2024 · strength 0.21
  7. Xiangmin Tong · 1 shared paper, 2023 · strength 0.19
  8. Kangsheng Tu · 1 shared paper, 2022 · strength 0.16
  9. Yiping Mou · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.